A recent study found a large increase in hospital adverse events during weeks with a high COVID-19 burden, with the impact hitting both COVID-19 and non-COVID-19 patients.
Upcoming ballot measures in Missouri, Nebraska, and Alaska may grant paid sick leave benefits to workers, aiming to alleviate financial pressures when ill and protect public health. While receiving broad support, the initiatives have not gained as much attention as other ballot measures.
Using novel nanotechnology, researchers detected femtogram-level inflammatory cytokines in Long COVID patients' plasma 18 months post-infection that directly impaired cardiomyocyte function - potentially explaining persistent cardiac symptoms and offering new diagnostic possibilities.
While FLiRT variants dominated the 2024 summer surge, rapid tests maintained accuracy by targeting stable nucleocapsid proteins rather than mutable spike proteins, according to BMJ report.
Tuberculosis now exceeds COVID-19 as the primary cause of infectious disease deaths in 2023, demanding urgent attention due to persistent challenges and funding shortages, according to a World Health Organization report.
Reuters
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A recent trial evaluated the efficacy of montelukast in reducing symptom duration among outpatients with mild to moderate COVID-19 infections, finding no statistically significant difference compared to placebo.
Researchers are making strides in developing the first successful mRNA vaccine against the highly contagious and difficult-to-treat Clostridioides difficile bacteria, with promising results in mice and nonhuman primates.
A recent study explores the impact of the COVID-19 pandemic on cancer detection in the U.S., revealing a significant drop in 2020 with certain subgroups still experiencing lower detection rates by 2021.